FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to organic chemistry, namely to a compound of formula
,
to its isomer forms and pharmaceutically acceptable salts. The invention also refers to a pharmaceutical composition based on the compound of formula I.
EFFECT: new compound increasing the HDL cholesterol concentration is prepared.
6 cl, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
3-PYRIDINE CARBOXAMIDE AND 2-PYRAZINE CARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | 2007 |
|
RU2454405C2 |
N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES AS AGENTS INCREASING LEVEL OF HDLP CHOLESTEROL | 2011 |
|
RU2540069C2 |
SYNTHESIS AND USE OF TETRAHYDROPYROLLO[3,2-c]PYRIDIN-4-ONE DERIVATIVES TO TREAT OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2006 |
|
RU2415856C2 |
PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CB1 INVERSE AGONISTS | 2006 |
|
RU2404164C2 |
METHOD OF TREATING ATHEROSCLEROSIS IN INDIVIDUALS WITH HIGH LEVEL OF TRIGLYCERIDES | 2012 |
|
RU2609200C2 |
COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
CONJUGATES OF FATTY ACIDS AND NIACIN AND APPLICATION THEREOF | 2010 |
|
RU2569063C2 |
4-CYCLOALKYL-SUBSTITUTED DERIVATIVES OF TETRAHYDROQUINOLINE AND USE THEREOF AS MEDICINE | 2005 |
|
RU2393151C2 |
IMIDAZOLE DERIVATIVES ACTIVE TO CB1 RECEPTOR | 2005 |
|
RU2377238C2 |
NIACIN MIMETICS AND METHOD FOR USE THEREOF | 2011 |
|
RU2588133C2 |
Authors
Dates
2015-02-20—Published
2010-09-08—Filed